Resistance to antibiotics used in Helicobacter pylori infection in children;Oporność na antybiotyki stosowane w zakażeniu Helicobacter pylori u dzieci

Polski Merkuriusz Lekarski

Volumn 16, Issue 96, 2004, Pages 543-546

  Maciorkowska, Elzbieta ^a,b   Kaczmarski, Maciej ^a   Kowalczuk, Jarosław ^a   Kondej Muszyńska, Katarzyna ^a   Roszko, Izabela ^a   Cieśla, Justyna ^a   Zielińska, Agata ^a   Musaibili, Sami ^a  

^a AM ^*  (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Children; Helicobacter pylori; Resistance to drugs

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; STOMACH BIOPSY;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; TETRACYCLINES; TREATMENT OUTCOME;

EID: 3242798856     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bontems P. i wsp.: Twellve year observation of primary and secondary antybiotic-resistance Helicobacter pylori strains in children. Pediatr. Infect. Dis. J., 2001, 20, 1033-38.
2. Boyanova L. i wsp.: Prevalence of resistant Helicobacter pylori isolates in Bulgarian children. J. Med. Microbiol., 2002, 5 (9), 786-790.
3. Boyanova L. i wsp.: The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin. Microbiol. Infect., 2002, 8 (7), 388-396.
4. Borody T.J. i wsp.: Omeprazole enhance efficacy of triple terapy in eradicating Helicobacter pylori. Gut, 1995, 37, 477-481.
5. Cabrita T. i wsp.: Features and trends in Helicobactre pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). J. Antimicrob. Chemother., 2000, 46, 1029-31.
6. Eggleston M.: Metronidazol [published erratum appears in Infect Control, 1987, 8, 48]. Infect Control, 1986, 7, 514-518.
7. Eggleston M.: Metronidazol [published erratum appears in Infect Control, 1987, 8, 48]. Infect Control, 1986, 7, 514-518.
8. Ganga-Zandzu P.S. i wsp.: Natural outcome of Helicobacter pylori infection in asymptomatic children: a two-year follow up study. Pediatrics, 1999, 104 (2), 216-221.
9. Gasbarrini A. i wsp.: Helicobacter pylori and extragastric diseases-other Helicobacters. Helicobacter, 2003, 8, supl. I, 68-76.
10. Gerrits M.M. i wsp.: 16S rRNA Mutation-Mediated Tetracyclin Resistance in Helicobacter pylori. Antimicrob. Agents. Chemother., 2002, 46 (9), 2996-3000.
11. Goodwin C.S.: Antimicrobial treatment of Helicobacter pylori infection. Clin. Infect. Dis., 1997, 25, 1023-26.
12. Kalach I/ i wsp.: Secondary resistance of Helicobacter pylori in children. XIV International Workshop: Gastroduodenal Pathology and Helicobacter pylori. Strasbourg, France, 5-8 Sep. 2001, 14/20.
13. Mentis A.F. i wsp.: Susceptibility of Helicobacter pylori strains isolated from children with gastritis to selected antibiotics. J. Antimicrob. Chemother., 1999, 44, 720-722.
14. Mukai T. i wsp.: Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol. Med. Microbiol., 2002, 32, 105-110.
15. Płaneta-Małecka I. i wsp.: Zakażenie Helicobacter pylori u dzieci, jego nastȩpstwa i leczenie. Med. Sci. Rev., 2002. 1, 5-17.
16. Rozynek E. i wsp.: Primary resistance to antymicrobial agents in clinical strains of Helicobacter pylori isolated from children in Poland during 1996-2000. XIV International Workshop: Gastroduodenal Pathology and Helicobacter pylori. Strasbourg, France, 5-8 Sep. 2001, 14/20.
17. Street M.E i wsp.: Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. Arch. Dis. Child., 2001, 84, 419-422.
18. Wolle K. i wsp.: Antibiotic susceptbility of H. pylori in German: stable primary resistance from 1995 to 2000. J. Med. Microbiol., 2002, 51, 705-709.
19. Yang Y.J. i wsp.: Prevalence and rapid identification of claritromycin - resistance H. pylori isolates in children. Paediatr. Infect. Dis. J., 2001, 20, 662-666.
20. Zwolińska-Wcisło i wsp.: Zasady postȩpowania w infekcji H. pylori. Wytyczne Europejskiego Towarzystwa Gastroenterologii w Opiece Podstawowej. Przegl. Lek., 2000, 11, 609-611.